https://www.proactiveinvestors.com.au/companies/news/1094748/recce-pharmaceuticals-bolsters-cash-position-with-a-3-67-million-tax-refund-ahead-of-phase-3-milestones-1094748.html
This is an ingested summary. Full reporting is available at the primary source below.